Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

This study has been terminated.
(The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication.)
Sponsor:
Collaborators:
Innovair
Takeda
Information provided by (Responsible Party):
Laval University
ClinicalTrials.gov Identifier:
NCT01701934
First received: October 3, 2012
Last updated: November 10, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)